Dimethyl fumarate suppresses Tc17 cell fate in autoimmunity via ROS accumulation
Dimethyl fumarate (DMF) is approved for treatment of relapsing remitting multiple sclerosis (RRMS), a chronic inflammatory disease of the central nervous system (CNS) that is caused by autoreactive T cells. The effect mechanism of DMF is not fully elucidated so far; however, a preferential impact on...
Salvato in:
Autore principale: | |
---|---|
Altri autori: | |
Natura: | Dissertation |
Lingua: | inglese |
Pubblicazione: |
Philipps-Universität Marburg
2018
|
Soggetti: | |
Accesso online: | PDF Full Text |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Lascia un commento!